Organisation paid for research Program year 2025 Source: CMS Open Payments

Associated Retina Consultants-Phoenix

Neither a doctor nor a teaching hospital

Research payments

$65,836

135 payments

Through program year 2025, Associated Retina Consultants-Phoenix is reported as receiving $65,836 in research payments, across 135 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$48,894	132
2024	Research	$16,942	3

Breakdown

Who paid Research payments · program years 2024–2025

Boehringer Ingelheim International GmbH $65,447 133 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $389 2 payments

Studies the money was for Research payments · program years 2024–2025

CRIMSON: A multicentre, randomised, sham-controlled (and active controlled in the USA), double-masked, 72-week trial to study the safety, tolerability, pharmacokinetics, and efficacy of 3 dosing regimens of intravitreal BI 764524 in patients with moderately severe to severe non-proliferative diabetic retinopathy $43,676 74 payments
BI 764524 Phase 2b $16,803 2 payments
A Phase 2 Randomized, double-masked, active-controlled study to evaluate efficacy and safety of two regimens of BI 771716 against pegcetacoplan in patients with geographic atrophy secondary to age-related macular degeneration. $3,009 38 payments
JADE: Phase II trial in patients with geographic atrophy: A randomized, double-masked, placebo-controlled, dose-finding study to evaluate the efficacy and safety of BI 1584862 $2,209 20 payments
-Ph II (12mo treatment) $139 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.